Roivant Sciences

Roivant Sciences

Biotechnology

New York, New York 26,096 followers

Reinventing Biopharma

About us

Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology. The therapies in development across our family of companies target a wide range of diseases including uterine fibroids, endometriosis, prostate cancer, Parkinson’s disease, diabetes, pulmonary arterial hypertension, and multiple rare and fatal pediatric conditions. We focus on disease areas where the magnitude of R&D investment from industry is disproportionately low relative to societal medical needs. In addition to our biopharmaceutical subsidiaries, we also build technology-focused Vants focused on improving the process of developing and commercializing medicines.

Website
http://www.roivant.com
Industry
Biotechnology
Company size
201-500 employees
Headquarters
New York, New York
Type
Public Company
Founded
2014

Locations

Employees at Roivant Sciences

Updates

Similar pages

Browse jobs

Funding

Roivant Sciences 7 total rounds

Last Round

Post IPO equity

US$ 230.0M

See more info on crunchbase